Cognitive Phenotypes, Brain Morphometry and the Detection of Cognitive Decline in Preclinical AD
Identifying a preclinical phase of Alzheimer’s Disease (PCAD) that is distinct from cognitive changes in healthy aging continues to be a major research focus. Combining neuropsychological and neuroimaging methodologies should improve our ability to differentiate healthy from pathological aging, alth...
Saved in:
Main Authors: | Mark W. Jacobson, Linda K. McEvoy, Anders Dale, Christine Fennema-Notestine |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Behavioural Neurology |
Online Access: | http://dx.doi.org/10.3233/BEN-2009-0229 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cortical Gyrification and Cognitive Decline in the Human Brain With Type 2 Diabetes Mellitus
by: Weiye Lu, et al.
Published: (2025-01-01) -
The gut microbiome, immune modulation, and cognitive decline: insights on the gut-brain axis
by: Ruyi Zhang, et al.
Published: (2025-01-01) -
Quantitative EEG and Cognitive Decline in Parkinson’s Disease
by: Vitalii V. Cozac, et al.
Published: (2016-01-01) -
Brain Hemodynamic Intermediate Phenotype Links Vitamin B12 to Cognitive Profile of Healthy and Mild Cognitive Impaired Subjects
by: Luca Cecchetti, et al.
Published: (2019-01-01) -
The Role of Lifestyle Behaviors on 20-Year Cognitive Decline
by: D. Cadar, et al.
Published: (2012-01-01)